An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A. Soucy, Steven Langston, James E. Brownell et al.|Nature|2009Cited by 2k
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Stephen Grossman et al.|Journal of Medicinal Chemistry|2021Cited by 205
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous RouteŠtěpán Vyskočil, Ji Zhang, David Cardin et al.|Journal of Medicinal Chemistry|2021Cited by 42